Journal of Multidisciplinary Healthcare · 2020 · 11 citations · 14 references
Public HealthHealth AdministrationHealth Services AdministrationHealth Services ResearchResource Utilization AnalysisTuberculosis ControlHealth Systems ManagementTuberculosis CareTuberculosis Diagnostic TestingTuberculosis Infection ControlTuberculosis PreventionTuberculosis Program ManagementIn-depth InterviewingPublic Facilities ManagementPublic Health FacilitiesQuantitative Data CollectionSemi-structured InterviewsThematic SynthesisTuberculosis Case Management
Background: Health facilities (HFs) need extensive ranges of anti-tuberculosis (TB) drugs and related TB laboratory commodities (LCs) for diagnosis, prevention, and treatment of TB and multi-drug-resistance (MDR)-TB. This study was aimed to assess anti-TB commodities management performance at public HFs of Dire Dawa city administration, Ethiopia. Methods: A cross-sectional study design in 16 HFs providing TB and MDR-TB related service using quantitative and qualitative method was conducted. Semi-structured questionnaires and observation checklists with logistic indicators assessment tools were used to collect data. We used an in-depth interview and analyzed using a thematic approach. Quantitative data were entered into Epi-Data version 3.1 and transported to SPSS version 20 to analyze the results. Chi-square was used to test the association and a P -value< 0.05 was statistically significant. Results: The majority(13; 81.3%) of HFs used a health commodity management information system. Forty-two (40%) bin cards (BCs) for first line anti-TB drugs were not updated, while 62.5% of BCs were updated for second line drugs. On average, 43% of HFs accurately reported a report and requisition format (RRF) had significant association with the presence of a logistic management information system (LMIS) and standard operating procedure ( P =0.019). Of the HFs, 50% had good storage conditions and guidelines ( P =0.041). Regimen change (56.3%; P =0.035), receive near expiry (56.3%; P =0.035), and defective practice to first expired-first-out (50%; P =0.007) were reasons for wastages. About 50% and 66.6% of HFs were stocked out for isoniazid 300 mg, rifampicin, isoniazid, pyrazinamide (RHZ fixed dose), and ethambutol 400 mg with a mean stock out duration of 10.8, 18.9, and 70.5 days, respectively. Regimen change (68.8%; P =0.026), low demand (56.3%; P =0.041), and delay to resupply (37.5%; P =0.041) were reasons for stock out of anti-TB commodities. Conclusion: Anti-TB drugs and LCs management performance of the HFs were found to be defective, which was confirmed by unsatisfactory data records, inconstant reports, deprived stock record accuracy, long lead time, high stock out rate, wastages, defective storage conditions, lack of training, and management support. Hence, respective organizations should improve their responsible activities to secure an uninterrupted supply of anti-TB drugs and LCs. Keywords: anti-TB drugs, MDR-TB, laboratory commodities, health facilities, Ethiopia
14
Adithya Cattamanchi, Cecily Miller, Asa Tapley et al. · BMC Health Services Research · 2015 · 103 citations · Full text
Antônio Guilherme Pacheco, Beatriz Grinsztejn, Maria de Jesus Mendes da Fonseca et al. · PLoS ONE · 2015 · 67 citations · Full text
Addisu Alemayehu Gube, Megbaru Debalkie Animut, Kalid Seid et al. · Tuberculosis Research and Treatment · 2018 · 57 citations · Full text
Kibriti Mehari, Tsehaye Asmelash, Haftamu Hailekiros et al. · Canadian Journal of Infectious Diseases and Medical Microbiology · 2019 · 52 citations · Full text
Public Health, Infectious Diseases, Diagnostic Microbiology +16
Senedu Bekele Gebreegziabher, Solomon Abebe Yimer, Gunnar Bjune · Tuberculosis Research and Treatment · 2016 · 49 citations · Full text
Public Health, Health Systems, Infectious Disease Control +17